HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bailey, L. B Articles by Berry, R. J Search for Related Content PubMed PubMed Citation Articles by Bailey, L. B Articles by Berry, R. J Agricola Articles by Bailey, L. B Articles by Berry, R. J

Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage^1,2,3

¹ From the Food Science and Human Nutrition Department, University of Florida, Gainesville, FL (LBB), and the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, GA (RJB)

ABSTRACT

Key research findings relative to the question of whether maternal use of folic acid before and during pregnancy reduces the chance that offspring will be born with a congenital heart defect or an orofacial cleft are reviewed in this paper. Observational studies in general support an association between maternal use of multivitamins containing folic acid and a reduction in the occurrence of congenital heart defects and orofacial clefts. Results from one randomized controlled trial (RCT) provide the strongest evidence that multivitamins prevent congenital heart defects, but this RCT did not provide evidence that multivitamins prevent orofacial clefts. In addition, most observational and interventional studies are not designed to detect an independent effect from folic acid. Early studies suggested that periconceptional multivitamin use was associated with an increased occurrence of both miscarriages and multiple births, which has resulted in a great deal of controversy about the safety of folic acid use during pregnancy. We also review reports that were designed to answer these questions with more definitive data. When more substantial evidence about the effect of periconceptional folic acid on the occurrence of congenital heart defects and orofacial clefts is reported, we will have additional support for promoting folic acid intervention programs. All women capable of becoming pregnant should continue to consume 400 µg/d of folic acid in addition to a healthy diet as advised.

Key Words: Folic acid • heart defects • orofacial clefts • miscarriages • multiple births

This article has been cited by other articles:

				G. Kocak, C. Onal, A. Kocak, C. Karakurt, O. Ates, S. R. Cayli, and S. Yologlu Prevalence and Outcome of Congenital Heart Disease in Patients With Neural Tube Defect J Child Neurol, May 1, 2008; 23(5): 526 - 530. [Abstract] [PDF]

				A. L. Moens, C. J. Vrints, M. J. Claeys, J.-P. Timmermans, H. C. Champion, and D. A. Kass Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1971 - H1977. [Abstract] [Full Text] [PDF]

				C Bille, J C Murray, and S F Olsen Folic acid and birth malformations BMJ, March 3, 2007; 334(7591): 433 - 434. [Full Text] [PDF]